SCHEMBL9924232

SCHEMBL9924232

CCOC(=O)N[C@H]1CC[C@H](N/C(=N\C(=O)c2ccc(F)c(F)c2)Nc2cccc(Cl)c2F)CC1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.39
CHRM1 P11229 1/20 0.37
DRD4 P21917 1/20 0.36
DRD3 P35462 1/20 0.36
TMEM97 Q5BJF2 1/20 0.36
SIGMAR1 Q99720 1/20 0.36
ACHE P22303 1/20 0.35
TSHR P16473 2/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
KDM4E B2RXH2 1/20 0.35
POLB P06746 1/20 0.35
AR P10275 2/20 0.35
MCHR1 Q99705 2/20 0.35
CNR1 P21554 1/20 0.35
CNR2 P34972 1/20 0.35
DRD2 P14416 1/20 0.35
LMNA P02545 1/20 0.34
CHRM3 P20309 1/20 0.34
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9924424 0.86 TRPV1 (0.45) ALDH1A1CHRM1TSHRSMN1; SMN2KDM4E
SCHEMBL17206711 0.85 CHRM1 (0.38) ALDH1A1CHRM1ARMCHR1DRD2
SCHEMBL9924156 0.85 CHRM1 (0.45) ALDH1A1CHRM1ARMCHR1DRD2
SCHEMBL17206685 0.85 MEN1 (0.49) ALDH1A1CHRM1TSHRSMN1; SMN2KDM4E
SCHEMBL9924270 0.83 HPGD (0.40) ALDH1A1CHRM1SMN1; SMN2MCHR1LMNA
SCHEMBL9924259 0.82 CHRM1 (0.38) ALDH1A1CHRM1POLBMCHR1DRD2
SCHEMBL17206702 0.82 CHRM1 (0.38) ALDH1A1CHRM1POLBMCHR1DRD2
SCHEMBL9924228 0.82 CHRM1 (0.38) ALDH1A1CHRM1POLBMCHR1DRD2
SCHEMBL9924432 0.82 CHRM1 (0.43) ALDH1A1CHRM1SMN1; SMN2POLBMCHR1
SCHEMBL17206716 0.82 CHRM1 (0.43) ALDH1A1CHRM1SMN1; SMN2POLBMCHR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9169199-B2 Cycloalkyl guanidine F1F0-ATPase inhibitors and therapeutic uses thereof LYCERA CORPORATION (US) 2015-10-27 US disclosed
WO-2012078867-A2 CYCLOALKYL GUANIDINE F1F0-ATPASE INHIBITORS AND THERAPEUTIC USES THEREOF LYCERA CORPORATION (US) 2012-06-14 WO disclosed